(VIANEWS) – Shares of NORDIC NANOVECTOR (Oslo Børs Benchmark Index_GI: NANOV.OL) rose by a staggering 16.44% in 5 sessions from kr0.73 to kr0.85 at 10:39 EST on Wednesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI is dropping 0.39% to kr1,240.53, following the last session’s downward trend.
NORDIC NANOVECTOR’s last close was kr0.82, 94.8% below its 52-week high of kr15.78.
About NORDIC NANOVECTOR
Nordic Nanovector ASA, a biopharmaceutical company, develops and commercializes therapeutics for hematological cancers in Norway. The company's lead product candidate is Betalutin, a CD37-targeting antibody-radionuclide-conjugate, which is in Phase 2b clinical trial for the treatment of patients with non-hodgkin lymphoma. Its preclinical development product also includes Alpha37, an anti-CD37 alphaparticle emitting radioimmunoconjugate for treating chronic lymphatic leukemia. The company has collaboration agreements with Paul Scherrer Institute; ArevaMed; LegoChem Bio; and Heidelberg Pharma. It also has a research collaboration with the University of Pennsylvania to generate a CD37-targeting CAR-T cell approach as a treatment for patients with B-cell malignancies. The company was formerly known as Nordic Nanovector AS and changed its name to Nordic Nanovector ASA in 2014. Nordic Nanovector ASA was incorporated in 2009 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NORDIC NANOVECTOR has a trailing twelve months EPS of kr-4.74.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -155.9%.
Yearly Top and Bottom Value
NORDIC NANOVECTOR’s stock is valued at kr0.85 at 10:39 EST, way below its 52-week high of kr15.78 and way above its 52-week low of kr0.67.
Moving Average
NORDIC NANOVECTOR’s worth is under its 50-day moving average of kr0.94 and way under its 200-day moving average of kr2.04.
Volume
Today’s last reported volume for NORDIC NANOVECTOR is 27935 which is 92.43% below its average volume of 1637460.
Volatility
NORDIC NANOVECTOR’s last week, last month’s, and last quarter’s current intraday variation average was a positive 3.03%, a negative 0.31%, and a positive 3.73%.
NORDIC NANOVECTOR’s highest amplitude of average volatility was 4.78% (last week), 3.32% (last month), and 3.73% (last quarter).
More news about NORDIC NANOVECTOR (NANOV.OL).
